The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Transaction in Own Shares

6 Jun 2022 17:00

RNS Number : 8932N
Hays PLC
06 June 2022
 

Hays plc

 

Transaction in own shares

 

 

Hays plc (the "Company") announces that it has purchased, in accordance with the authority granted by shareholders at the 2021 Annual General Meeting of the Company, the following number of its ordinary shares of 1p each on the London Stock Exchange through UBS AG as part of its £75 million share buyback programme announced on 28 April 2022.

 

 

Date of purchase:

6 June 2022

 

Number of ordinary shares purchased:

350,000

 

Highest price per share (pence per share):

125.30p

 

Lowest price per share (pence per share):

122.10p

 

Average price per share (pence per share)

123.5787p

 

 

The purchased shares will be cancelled.

 

Following the purchase and cancellation of these shares, the Company will have 1,658,953,685 ordinary shares in issue (excluding 16,358,090 treasury shares).

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual purchases is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/8932N_1-2022-6-6.pdf

 

 

Chris Winters

Deputy Company Secretary

 

Enquiries: +44 (0) 20 3978 2520

 

LEI code: 213800QC8AWD4BO8TH08

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSSWFIMEESEIM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.